Clinical trial
Combination Chemotherapy With or Without Hyperthermia Therapy in Treating…
NCT00003052 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003052 |
|---|---|
| Title | Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma |
| Official title | Randomized Study Comparing Neoadjuvant Chemotherapy Etoposide + Ifosfamide + Adriamycin (EIA) Combined With Regional Hyperthermia (RHT) Versus Neoadjuvant Chemotherapy Alone in the Treatment of High-Risk Soft Tissue Sarcomas in Adults |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Collaborators | The European Society for Hyperthermic Oncology |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | doxorubicin hydrochloride, etoposide, ifosfamide, conventional surgery, hyperthermia treatment, radiation therapy |
| Enrollment | 340 |
| Start date | Jul 1, 1997 |
| Completion | Jun 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: